Cidofovir and Nephropathy - a phase IV clinical study of FDA data

Summary:

Nephropathy is reported as a side effect among people who take Cidofovir (cidofovir), especially for people who are female, 40-49 old, also take Methylprednisolone, and have Cytomegalovirus infection.

The phase IV clinical study analyzes which people have Nephropathy when taking Cidofovir. It is created by eHealthMe based on reports of 1,321 people who have side effects when taking Cidofovir from the FDA, and is updated regularly.

What is Cidofovir?

Cidofovir has active ingredients of cidofovir. eHealthMe is studying from 1,321 Cidofovir users. Check the latest studies of Cidofovir.

What is Nephropathy?

Nephropathy (damage to or disease of a kidney) is found to be associated with 899 drugs and 734 conditions by eHealthMe. Check the latest studies of Nephropathy.

On Jul, 19, 2026

1,321 people reported to have side effects when taking Cidofovir.
Among them, 12 people (0.91%) have Nephropathy.

Among these 12 people:

What is the gender of people who have Nephropathy when taking Cidofovir? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Nephropathy when taking Cidofovir? *

What are other drugs people take besides Cidofovir? *

What are other side effects people have besides Nephropathy? *

Cytomegalovirus Infection: 9 people, 75.00%
Thrombocytopenia (decrease of platelets in blood): 8 people, 66.67%
Hepatic Function Abnormal: 7 people, 58.33%
Gastric Disorder (disease of stomach): 7 people, 58.33%
Viral Uveitis (inflammation at any point of the uveal track): 6 people, 50.00%
Transplant Rejection (a transplant material is not worked): 6 people, 50.00%
Renal Impairment (severely reduced kidney function): 4 people, 33.33%
C-Reactive Protein Increased: 3 people, 25.00%
Diarrhea: 3 people, 25.00%
Drug Resistance (reduction in effectiveness of a drug): 3 people, 25.00%

What are the existing conditions these people have? *

Cytomegalovirus Infection: 4 people, 33.33%
Polyomavirus-Associated Nephropathy (polyomavirus-associated kidney disease): 1 person, 8.33%
Immunodeficiency Disorders: 1 person, 8.33%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cidofovir and have Nephropathy?

- Check whether Nephropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cidofovir:

Cidofovir (1,321 reports)

Nephropathy treatments and more:

Nephropathy (16,529 reports)

Browse all side effects of Cidofovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephropathy:

Nephropathy (899 drugs)

Browse all the conditions that are associated with Nephropathy:

Nephropathy (734 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cidofovir (the active ingredients of Cidofovir) and Cidofovir (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.